Biotechnology company Discovery Laboratories, Inc. (DSCO) Tuesday said it appointed Dr. Thomas Miller as Chief Operating Officer, Charles Katzer as Chief Technical Officer, and John Cooper as President and Chief Financial Officer. These positions will report directly to Thomas Amick, Chairman of the board and Interim Chief Executive Officer of Discovery Labs.
In addition, the company said it intends to recruit for the Chief Executive Officer role to fill the position in 2011.
Miller, PhD., newly appointed Chief Operating Officer will have responsibility for product development, regulatory affairs, and corporate and commercial development for the company. His relevant biopharmaceutical experience includes product development and commercial operations with Pfizer, Novartis, BASF Pharmaceuticals, Pharmacia, and Johnson & Johnson.
Charles Katzer new Chief Technical Officer will have responsibility for manufacturing operations, aerosol device development, formulations development, quality control and assurance, and analytical services. He has over 35 years of related experience in drug manufacturing and supply, device development, and quality operations within the biopharmaceutical industry including Biological Specialties, MedImmune, U.S. Bioscience, Rhone-Poulenc Rorer and Baxter, and has successfully developed and manufactured small molecule and complex biotechnology drug products.
John Cooper has been appointed President and Chief Financial Officer and will be responsible for the strategic and organizational development of the company while retaining overall responsibility for the company's financial operations. Cooper has over 25 years of experience in the life sciences industry including C.R. Bard, ENI Diagnostics, DNX Corp., and Chrysalis Corp.
For comments and feedback: editorial@rttnews.com